Mr. Lee is the Chief Executive Officer and member of the Board of Pacira BioSciences, Inc., a publicly traded pharmaceutical company targeting non-opioid pain management and regenerative health solutions. Prior to joining Pacira, he served as Chief Executive Officer of Forma Therapeutics Inc., a publicly traded biopharmaceutical company focused on rare hematologic diseases and cancers, from March 2019 until its acquisition by Novo Nordisk in October 2022. During his tenure at Forma, Mr. Lee transformed the organization from an early-stage drug discovery company into one focused on the clinical development of lead assets in rare hematologic disorders and cancer. Prior to Forma, Mr. Lee served as Senior Vice President, Global Product Strategy and Therapeutic Area Head for Immunology, Ophthalmology and Infectious Diseases at Genentech, Inc., a member of the Roche Group. Mr. Lee’s 13-year tenure at Genentech included leadership positions of increasing scope and responsibility focused on delivering transformative medicines to patients and driving the growth of multiple in oncology, immunology and ophthalmology products to blockbuster/multi-blockbuster status. Prior to Genentech, Mr. Lee spent approximately 13 years across Novartis, Janssen and Eli Lilly. He received a Bachelor of Science degree in Chemical Engineering from Vanderbilt University and an MBA from the Wharton Graduate School of Business.
Mr. Lee has served as director of Bolt Biotherapeutics, a publicly traded biotechnology company targeting immunotherapies, from November 2021 to September 2024, and has served as an Advisor to Lightstone Ventures, a venture capital firm focused on medical devices and biopharmaceuticals, since January 2023.
What is Frank D. Lee's net worth?
The estimated net worth of Frank D. Lee is at least $244.47 thousand as of May 19th, 2026. Mr. Lee owns 49,339 shares of Bausch Health Cos stock worth more than $244,475 as of June 4th. This net worth evaluation does not reflect any other investments that Mr. Lee may own. Learn More about Frank D. Lee's net worth.
How do I contact Frank D. Lee?
Has Frank D. Lee been buying or selling shares of Bausch Health Cos?
During the last ninety days, Frank D. Lee has sold $132,796.08 in Bausch Health Cos stock. Most recently, Frank D. Lee sold 24,456 shares of the business's stock in a transaction on Tuesday, May 19th. The shares were sold at an average price of $5.43, for a transaction totalling $132,796.08. Following the completion of the sale, the director now directly owns 49,339 shares of the company's stock, valued at $267,910.77. Learn More on Frank D. Lee's trading history.
Who are Bausch Health Cos' active insiders?
Bausch Health Cos' insider roster includes Christina Ackermann (EVP), Seana Carson (EVP), Richard DeSchutter (Director), Sam Eldessouky (CFO), Joseph Gordon (Insider), William Humphries (Insider), Frank Lee (Director), Steven Miller (Director), John Paulson (Director), Robert Spurr (Insider), and Amy Wechsler (Director). Learn More on Bausch Health Cos' active insiders.
Are insiders buying or selling shares of Bausch Health Cos?
In the last year, Bausch Health Cos insiders bought shares 8 times. They purchased a total of 44,316,834 shares worth more than $369,628,560.14. In the last year, insiders at the sold shares 1 times. They sold a total of 24,456 shares worth more than $132,796.08. The most recent insider tranaction occured on May, 19th when Director Frank D Lee sold 24,456 shares worth more than $132,796.08. Insiders at Bausch Health Cos own 20.7% of the company.
Learn More about insider trades at Bausch Health Cos. Information on this page was last updated on 5/19/2026.
